Literature DB >> 19681324

Bifocal and trifocal bone transport for failed limb reconstruction after tumour resection.

Barakat El-Alfy1, Hani El-Mowafi, Samir Kotb.   

Abstract

The aim of the present study is to assess the results of bifocal and trifocal bone transport for elimination of bone defects due to failed limb reconstruction after tumour resection. Thirteen patients, nine with giant-cell tumour and four with osteosarcoma, with bone defects resulting from wide tumour resection were managed by bone transport with an Ilizarov frame. The ages ranged from 12 to 46 years. Bone transport was used as a second line of management after failure of other modalities for reconstruction. According to the Enneking system for the functional evaluation after surgical treatment of musculoskeletal tumours, the percentage rating of function was 47% in one case, 70% in 2 cases and more than 85% in 10 cases. Most of the complications were treated successfully during the course of treatment. Bone transport with two or three osteotomies is a reliable method for eliminating bone defects as a limb salvage procedure after failure of other modalities for reconstruction.

Entities:  

Mesh:

Year:  2009        PMID: 19681324

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  3 in total

1.  Mechanical solutions to salvage failed distraction osteogenesis in large bone defect management.

Authors:  Dmitry Y Borzunov; Alexander L Shastov
Journal:  Int Orthop       Date:  2018-06-23       Impact factor: 3.075

2.  Bone transport for reconstruction of large bone defects after tibial tumor resection: a report of five cases.

Authors:  Zhengming Yang; Huimin Tao; Zhaoming Ye; Libin Jin; Nong Lin; Disheng Yang
Journal:  J Int Med Res       Date:  2018-05-29       Impact factor: 1.671

3.  Bone Transport for Reconstruction in Benign Bone Tumors.

Authors:  Chang Seon Oh; Sung Taek Jung; Yong Jin Cho; Yeong Seub Ahn; Bo Ram Na
Journal:  Clin Orthop Surg       Date:  2015-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.